BioAtla (BCAB) Total Liabilities (2020 - 2026)

BioAtla (BCAB) has reported Total Liabilities for 7 consecutive years, with $45.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Liabilities rose 4.26% year-over-year to $45.7 million; the trailing twelve-month figure through Jun 2026 stood at $45.7 million (up 4.26% YoY), and the FY2025 full-year result was $50.0 million, up 31.08% from the prior year.
• Total Liabilities steadied at $45.7 million in Q2 2026 per BCAB's latest filing, from $45.9 million in the prior quarter.
• Across five years, Total Liabilities topped out at $56.7 million in Q3 2023 and bottomed at $37.3 million in Q2 2024.
• Historically, Total Liabilities has averaged $45.2 million across 5 years, with a median of $45.8 million in 2026.
• The sharpest annual moves came in 2024 and 2025: Total Liabilities tumbled 32.39% in 2024, then soared 31.08% in 2025.
• Over 5 years, Total Liabilities stood at $45.4 million in 2022, then grew by 7.91% to $49.0 million in 2023, then declined by 22.11% to $38.2 million in 2024, then surged by 31.08% to $50.0 million in 2025, then dropped by 8.55% to $45.7 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $45.7 million, $45.9 million, and $50.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.